Jon Wigginton
Equibles does not estimate personal net worth.
About Jon Wigginton
The proxy statement of Cullinan Therapeutics, Inc. reports total compensation of $4,544,022 for Jon Wigginton in fiscal 2020, including a base salary of $321,122. Disclosed compensation is on record for 4 fiscal years.
Affiliation history
-
Cullinan Therapeutics, Inc. (CGEM)
Proxy statement
Start not stated–2021-04-29
Last confirmed by a filing; no departure on record
-
Macrogenics Inc (MGNX)
Proxy statement
Start not stated–2020-03-27
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Cullinan Therapeutics, Inc. (CGEM) | Chief Medical Officer | $321,122 | $4,544,022 |
| 2019 | Macrogenics Inc (MGNX) | Senior Vice President, Clinical Development and Chief Medical Officer | $453,454 | $1,942,251 |
| 2018 | Macrogenics Inc (MGNX) | Senior Vice President, Clinical Development and Chief Medical Officer | $460,000 | $1,976,107 |
| 2017 | Macrogenics Inc (MGNX) | Senior Vice President, Clinical Development and Chief Medical Officer | $445,050 | $1,516,458 |
Recent activity
No call appearances or filed executive changes recorded yet.